Pharsight

Drugs that contain Acyclovir; Hydrocortisone

1. Xerese patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE39264 BAUSCH Pharmaceutical combination
Feb, 2016

(8 years ago)

US6514980 BAUSCH Nucleoside analogs in combination therapy of herpes simplex infections
Jan, 2017

(7 years ago)

US7223387 BAUSCH Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
Feb, 2021

(3 years ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Jan 22, 2017
New Combination(NC) Jul 31, 2012

Market Authorisation Date: 31 July, 2009

Treatment: New combination product for the early treatment of recurrent herpes labialis (cold sores) to reduce the likelihood of ulcerative cold sores and to shorten the lesion healing time in adults and adolesc...

Dosage: CREAM;TOPICAL

More Information on Dosage

XERESE family patents

Family Patents